Financials data is unavailable for this security.
View more
Year on year Fisher & Paykel Healthcare Corporation Ltd had net income fall -47.02% from 250.30m to 132.60m despite a 10.23% increase in revenues from 1.58bn to 1.74bn. An increase in the selling, general and administrative costs as a percentage of sales from 27.32% to 28.28% was a component in the falling net income despite rising revenues.
| Gross margin | 59.93% |
|---|---|
| Net profit margin | 7.61% |
| Operating margin | 14.65% |
| Return on assets | 5.91% |
|---|---|
| Return on equity | 7.55% |
| Return on investment | 6.96% |
More ▼
Cash flow in NZDView more
In 2024, cash reserves at Fisher & Paykel Healthcare Corporation Ltd fell by 35.90m. However, the company earned 429.60m from its operations for a Cash Flow Margin of 24.65%. In addition the company used 339.00m on investing activities and also paid 128.70m in financing cash flows.
| Cash flow per share | 0.4212 |
|---|---|
| Price/Cash flow per share | 89.50 |
| Book value per share | 3.01 |
|---|---|
| Tangible book value per share | 2.86 |
More ▼
Balance sheet in NZDView more
| Current ratio | 1.83 |
|---|---|
| Quick ratio | 0.9987 |
| Total debt/total equity | 0.1075 |
|---|---|
| Total debt/total capital | 0.0971 |
More ▼
Growth rates in NZD
SmartText is unavailable
| Div yield(5 year avg) | 1.37% |
|---|---|
| Div growth rate (5 year) | 12.29% |
| Payout ratio (TTM) | 103.50% |
| EPS growth(5 years) | -8.97 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -47.32 |
More ▼
